Skip to Content

Moderna Starts Testing COVID-19 Vaccine in Younger Children

TUESDAY, March 16, 2021 -- Moderna has launched a study of its COVID-19 vaccine in children younger than 12 years, including babies as young as 6 months.

The company expects to enroll 6,750 healthy children in the United States and Canada, but Moderna spokeswoman Colleen Hussey did not reveal how many had already been signed up or received their first shots, The New York Times reported.

In another study, Moderna is testing its vaccine in 3,000 older children, ages 12 to 17 years, and may have results by summer. But even if the results are favorable, the vaccine would not be immediately available because it would have to be approved for use in children.

"There's a huge demand to find out about vaccinating kids and what it does," David Wohl, M.D., medical director of the vaccine clinic at the University of North Carolina, told The Times. He is not involved in the studies.

The New York Times Article

© 2021 HealthDay. All rights reserved.

Read this next

Vaccinating Lactating Mothers May Protect Infants From COVID-19

WEDNESDAY, April 21, 2021 -- Antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are detectable in the breast milk of lactating women up to 80 days...

Mechanism ID'd for Thrombosis After ChAdOx1 nCoV-19 Vaccine

WEDNESDAY, April 21, 2021 -- A pathogenic platelet factor 4 (PF4)-dependent syndrome has been observed rarely after administration of the ChAdOx1 nCoV-19 vaccine, according to a...

Sex Disparities in COVID-19 Deaths Not Seen Across Race

WEDNESDAY, April 21, 2021 -- Sex disparities in COVID-19 mortality do not hold across racial groups, according to a study published online April 5 in the Journal of General...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.